• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.25 Down 0.00(0.52%) 4:00PM EST
    |After Hours : 0.23 Down 0.02 (7.48%) 4:52PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 45   36   76   36  
    Cost of Revenue306  294  323  156  
    Gross Profit (261) (258) (247) (120)
    Operating Expenses
    Research Development1,894  2,330  2,326  1,533  
    Selling General and Administrative2,174  2,497  2,539  1,759  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,329) (5,085) (5,112) (3,412)
    Income from Continuing Operations
    Total Other Income/Expenses Net130  132  1,279  219  
    Earnings Before Interest And Taxes(4,199)(4,953)(3,833)(3,193)
    Interest Expense3  3  3  2  
    Income Before Tax(4,202)(4,956)(3,836)(3,195)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,202)(4,956)(3,836)(3,195)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,202) (4,956) (3,836) (3,195)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (4,202) (4,956) (3,836) (3,195)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.